The Department of Science and Technology (DOST) said Friday, Nov. 26, that initial results of the clinical study on tawa-tawa (Euphorbia hirta) as adjunctive treatment for coronavirus disease showed that tawa-tawa capsules are safe for patients who are experiencing mild COVID-19 symptoms.
Tawa-ta
Tawa-tawa (Euphorbia hirta) extract is proving to be an effective adjunctive coronavirus disease (COVID-19) treatment for mild to moderate cases, the Department of Science and Technology (DOST) disclosed.
Tawa-tawa (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development (R
The Department of Science and Technology (DOST) is seeking more participants for its ongoing randomized controlled clinical trial on the efficacy and safety of tawa-tawa (Euphorbia hirta) extract as an adjunctive coronavirus disease (COVID-19) treatment for mild to moderate cases.
Tawa-tawa (Man
68 COVID-19 patients already recruited to participate in PH s tawa-tawa clinical trial – Manila Bulletin mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
Published June 27, 2021, 2:37 PM
The “preliminary” results of the clinical trials on the use of the Virgin Coconut Oil (VCO), and lagundi (Chinese chaste tree) as a coronavirus disease (COVID-19) therapeutic or supplement could be expected by next month, an official of the Philippine Council for Health Research and Development (PCHRD) of the Department of Science and Technology (DOST-PCHRD) said on Sunday, June 27.
Virgin coconut oil (upper photo), Tawa-tawa (lower left), Lagundi (lower right) (MANILA BULLETIN FILE PHOTOS)
DOST-PCHRD Executive Director Dr. Jaime C. Montoya said the VCO clinical trial at the Philippine General Hospital (PGH) will be completed by end of this month and the initial analysis of the data is expected to be conducted, while the project team handling the lagundi clinical trials is currently conducting their data analysis.